March Madness — 25% Off — Limited Time
Get All the Market Moving News, Squawk, and Mentorship NOW
get this deal
Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
March Madness — 25% Off — Limited Time
Get All the Market Moving News, Squawk, and Mentorship NOW
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Sports
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Sports
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Aptinyx Inc Com
(OTC:APTX)
Intraday
$0.096
0
[0.00%]
After-Hours
$0.09
-0.0060
[-6.25%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.096
0
[0.00%]
At close: Dec 29
$0.09
-0.0060
[-6.25%]
After Hours: 9:26AM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Aptinyx Inc Com Stock (OTC:APTX)
Aptinyx Inc Com Stock (OTC: APTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, May 05, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
May 5, 2023, 1:31PM
Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
May 5, 2023, 12:56PM
Friday, March 31, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Mar 31, 2023, 11:46AM
Aptinyx Evaluates Strategic Alternatives For Its Future After Failed Trials, 60% Layoffs
Vandana Singh
-
Mar 31, 2023, 10:30AM
Thursday, March 30, 2023
Aptinyx Q4 EPS $(0.18) Beats $(0.19) Estimate
Happy Mohamed
-
Mar 30, 2023, 4:48PM
Friday, March 24, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Mar 24, 2023, 1:30PM
Why Heron Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Mar 24, 2023, 8:21AM
Thursday, March 23, 2023
Aptinyx Granted European Patent Titled 'Spiro-lactam Nmda Receptor Modulators And Uses Thereof (for The Treatment Of Conditions Such As Depression And Related Disorders)'
Benzinga Newsdesk
-
Mar 23, 2023, 4:00PM
Wednesday, March 15, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Mar 15, 2023, 1:25PM
Wednesday, March 08, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Mar 8, 2023, 10:59AM
Tuesday, March 07, 2023
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
Benzinga Insights
-
Mar 7, 2023, 10:00AM
HC Wainwright & Co. Downgrades Aptinyx to Neutral
Benzinga Newsdesk
-
Mar 7, 2023, 6:17AM
Wednesday, March 01, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Mar 1, 2023, 1:30PM
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
Benzinga Insights
-
Mar 1, 2023, 10:00AM
SVB Leerink Downgrades Aptinyx to Market Perform, Announces $0.5 Price Target
Benzinga Newsdesk
-
Mar 1, 2023, 9:22AM
Tuesday, February 28, 2023
Nasdaq Gains 80 Points; Chico's FAS Shares Spike Higher
Lisa Levin
-
Feb 28, 2023, 2:21PM
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Feb 28, 2023, 12:56PM
Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Feb 28, 2023, 12:54PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Feb 28, 2023, 12:31PM
Crude Oil Rises Over 2%; Consolidated Communications Shares Plummet
Lisa Levin
-
Feb 28, 2023, 12:01PM
Aptinyx shares are trading lower after the company reported NYX-458 did not demonstrate sufficient efficacy in the Phase 2 study to support further development by the company.
Benzinga Newsdesk
-
Feb 28, 2023, 9:49AM
Within Six Months Aptinyx's Another Development Candidate Goes Up In Smoke
Vandana Singh
-
Feb 28, 2023, 8:13AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Feb 28, 2023, 8:06AM
Why Catalyst Biosciences Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Feb 28, 2023, 7:57AM
Monday, February 27, 2023
Aptinyx Shares Resume Trade, Move Lower
Michael Horton
-
Feb 27, 2023, 4:37PM
Aptinyx Reports Results From Phase 2 Study Of NYX-458 In Cognitive Impairment Associated With Parkinson's Disease And Dementia With Lewy Bodies And Provides Pipeline And Corporate Update; Will Undertake Cost-Cutting Measures And Explore Alternatives
Happy Mohamed
-
Feb 27, 2023, 4:12PM
Friday, February 17, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Feb 17, 2023, 4:31PM
Tuesday, February 14, 2023
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Feb 14, 2023, 2:26PM
Thursday, February 09, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Feb 9, 2023, 4:31PM
Wednesday, January 18, 2023
Why Arcimoto Shares Are Trading Lower By 44%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Jan 18, 2023, 7:50AM
Thursday, December 29, 2022
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Dec 29, 2022, 4:31PM
Tuesday, December 27, 2022
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Dec 27, 2022, 8:07AM
Why Tuesday Morning Shares Are Trading Lower By 38%; Here Are 31 Stocks Moving Premarket
Lisa Levin
-
Dec 27, 2022, 6:40AM
Monday, December 26, 2022
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Dec 26, 2022, 12:32PM
Wednesday, November 16, 2022
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Nov 16, 2022, 8:08AM
Tuesday, November 08, 2022
Aptinyx Q3 EPS $(0.23) Beats $(0.24) Estimate
Benzinga Newsdesk
-
Nov 8, 2022, 4:09PM
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
Lisa Levin
-
Nov 8, 2022, 5:00AM
Earnings Scheduled For November 8, 2022
Benzinga Insights
-
Nov 8, 2022, 4:32AM
Monday, November 07, 2022
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Nov 7, 2022, 1:28PM
Thursday, November 03, 2022
Aptinyx Announces Finalization Of $5.6M Grant Under Nih's HEAL Initiative Supporting Development Of NYX-783 For Opioid Use Disorder
Benzinga Newsdesk
-
Nov 3, 2022, 7:42AM
Friday, October 21, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Oct 21, 2022, 1:26PM
Thursday, October 20, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Oct 20, 2022, 11:46AM
Wednesday, October 19, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 19, 2022, 12:54PM
Tuesday, October 11, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 11, 2022, 12:47PM
Monday, October 10, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Oct 10, 2022, 12:29PM
Friday, October 07, 2022
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Oct 7, 2022, 6:14PM
Friday, August 26, 2022
HC Wainwright & Co. Maintains Buy on Aptinyx, Lowers Price Target to $1
Benzinga Newsdesk
-
Aug 26, 2022, 6:16AM
Thursday, August 25, 2022
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
Ragothaman Srinivasan
-
Aug 25, 2022, 6:43PM
Aptinyx Completes Enrollment In Phase 2 Study Of NYX-458 In Cognitive Impairment Associated With Parkinson's Disease And Dementia With Lewy Bodies
Benzinga Newsdesk
-
Aug 25, 2022, 7:37AM
Tuesday, August 16, 2022
Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2022
Benzinga Insights
-
Aug 16, 2022, 10:12AM
Show more